ArticleIntestinal research2019

Infliximab biosimilar CT-P13 is interchangeable with its originator for patients with inflammatory bowel disease in real world practice.

Tomoo Nakagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.